These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 26445817)

  • 1. gespeR: a statistical model for deconvoluting off-target-confounded RNA interference screens.
    Schmich F; Szczurek E; Kreibich S; Dilling S; Andritschke D; Casanova A; Low SH; Eicher S; Muntwiler S; Emmenlauer M; Rämö P; Conde-Alvarez R; von Mering C; Hardt WD; Dehio C; Beerenwinkel N
    Genome Biol; 2015 Oct; 16():220. PubMed ID: 26445817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved pathway reconstruction from RNA interference screens by exploiting off-target effects.
    Srivatsa S; Kuipers J; Schmich F; Eicher S; Emmenlauer M; Dehio C; Beerenwinkel N
    Bioinformatics; 2018 Jul; 34(13):i519-i527. PubMed ID: 29950000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific inhibition of diverse pathogens in human cells by synthetic microRNA-like oligonucleotides inferred from RNAi screens.
    Franceschini A; Meier R; Casanova A; Kreibich S; Daga N; Andritschke D; Dilling S; Rämö P; Emmenlauer M; Kaufmann A; Conde-Álvarez R; Low SH; Pelkmans L; Helenius A; Hardt WD; Dehio C; von Mering C
    Proc Natl Acad Sci U S A; 2014 Mar; 111(12):4548-53. PubMed ID: 24616511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erratum to: gespeR: a statistical model for deconvoluting off-target-confounded RNA interference screens.
    Schmich F; Szczurek E; Kreibich S; Dilling S; Andritschke D; Casanova A; Low SH; Eicher S; Muntwiler S; Emmenlauer M; Rämo P; Conde-Alvarez R; von Mering C; Hardt WD; Dehio C; Beerenwinkel N
    Genome Biol; 2015 Oct; 16():233. PubMed ID: 26490954
    [No Abstract]   [Full Text] [Related]  

  • 5. An siRNA designing tool with a unique functional off-target filtering approach.
    Das S; Ghosal S; Kozak K; Chakrabarti J
    J Biomol Struct Dyn; 2013; 31(11):1343-57. PubMed ID: 23140209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. cSSMD: assessing collective activity for addressing off-target effects in genome-scale RNA interference screens.
    Zhang XD; Santini F; Lacson R; Marine SD; Wu Q; Benetti L; Yang R; McCampbell A; Berger JP; Toolan DM; Stec EM; Holder DJ; Soper KA; Heyse JF; Ferrer M
    Bioinformatics; 2011 Oct; 27(20):2775-81. PubMed ID: 21846737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNAither, an automated pipeline for the statistical analysis of high-throughput RNAi screens.
    Rieber N; Knapp B; Eils R; Kaderali L
    Bioinformatics; 2009 Mar; 25(5):678-9. PubMed ID: 19168909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soft computing model for optimized siRNA design by identifying off target possibilities using artificial neural network model.
    Murali R; John PG; Peter S D
    Gene; 2015 May; 562(2):152-8. PubMed ID: 25725126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A computational study of off-target effects of RNA interference.
    Qiu S; Adema CM; Lane T
    Nucleic Acids Res; 2005; 33(6):1834-47. PubMed ID: 15800213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guidelines for the selection of effective short-interfering RNA sequences for functional genomics.
    Ui-Tei K; Naito Y; Saigo K
    Methods Mol Biol; 2007; 361():201-16. PubMed ID: 17172713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA interference targeting transforming growth factor-beta type II receptor suppresses ocular inflammation and fibrosis.
    Nakamura H; Siddiqui SS; Shen X; Malik AB; Pulido JS; Kumar NM; Yue BY
    Mol Vis; 2004 Oct; 10():703-11. PubMed ID: 15475878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of gene rankings from RNAi screens.
    Siebourg J; Merdes G; Misselwitz B; Hardt WD; Beerenwinkel N
    Bioinformatics; 2012 Jun; 28(12):1612-8. PubMed ID: 22513992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell division autoantigen 1 enhances signaling and the profibrotic effects of transforming growth factor-β in diabetic nephropathy.
    Tu Y; Wu T; Dai A; Pham Y; Chew P; de Haan JB; Wang Y; Toh BH; Zhu H; Cao Z; Cooper ME; Chai Z
    Kidney Int; 2011 Jan; 79(2):199-209. PubMed ID: 20962744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. siRNAs: their potential as therapeutic agents--Part I. Designing of siRNAs.
    Hajeri PB; Singh SK
    Drug Discov Today; 2009 Sep; 14(17-18):851-8. PubMed ID: 19540928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Properties of short double-stranded RNAs carrying randomized base pairs: toward better controls for RNAi experiments.
    Zagalak JA; Menzi M; Schmich F; Jahns H; Dogar AM; Wullschleger F; Towbin H; Hall J
    RNA; 2015 Dec; 21(12):2132-42. PubMed ID: 26516083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-throughput RNA interference strategies for target discovery and validation by using synthetic short interfering RNAs: functional genomics investigations of biological pathways.
    Sachse C; Krausz E; Krönke A; Hannus M; Walsh A; Grabner A; Ovcharenko D; Dorris D; Trudel C; Sönnichsen B; Echeverri CJ
    Methods Enzymol; 2005; 392():242-77. PubMed ID: 15644186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The design, selection, and evaluation of highly specific and functional siRNA incorporating unlocked nucleobase analogs.
    Vaish N; Agarwal P
    Methods Mol Biol; 2013; 942():111-34. PubMed ID: 23027048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Explicit Modeling of siRNA-Dependent On- and Off-Target Repression Improves the Interpretation of Screening Results.
    Riba A; Emmenlauer M; Chen A; Sigoillot F; Cong F; Dehio C; Jenkins J; Zavolan M
    Cell Syst; 2017 Feb; 4(2):182-193.e4. PubMed ID: 28215525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common seed analysis to identify off-target effects in siRNA screens.
    Marine S; Bahl A; Ferrer M; Buehler E
    J Biomol Screen; 2012 Mar; 17(3):370-8. PubMed ID: 22086724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the art of identifying effective and specific siRNAs.
    Pei Y; Tuschl T
    Nat Methods; 2006 Sep; 3(9):670-6. PubMed ID: 16929310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.